A new study for people with mild memory problems
Part of Brain & nervous system, Mental health clinical trials.
This trial is testing an experimental medicine called QLH2405 in two groups: healthy volunteers (to check safety) and people with mild memory problems due to Alzheimer's. If you qualify, the study may help find out if this new treatment is safe and could slow down memory decline.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 65 years old for the healthy volunteer part, or between 50 and 85 for the Alzheimer's part.
- If you have mild memory problems, you need a doctor's diagnosis of mild cognitive impairment (MCI) or mild Alzheimer's disease.
- You need to have had memory problems for at least 6 months.
- A special brain scan must show changes linked to Alzheimer's disease.
- You need a family member or friend to come with you to all visits.
- You must agree to use birth control for the study and 9 months after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental tablet called RP902 for people with mild cognitive impairment (early memory and thinking problems). The goal is to see if it can safely help slow down memory decline.
This study looks at how well people with Alzheimer’s disease (AD) or mild cognitive impairment (MCI) perform on standardized memory/brain tests. It may help researchers understand changes over time, and whether certain types of brain signals or test results track with the condition.
This trial tests a new drug called CM383 in people with mild cognitive impairment or mild Alzheimer's disease. The goal is to see if it can help slow down memory loss.
This trial tests a new medicine called LY4006895 in two groups: healthy volunteers and people with early symptomatic Alzheimer's disease. It aims to see how the drug works in the body and if it might help memory and thinking.
This trial tests whether a supplement called Neuroaid II can help people with mild to moderate Alzheimer's disease. It is a pill taken alongside your usual Alzheimer's treatments, and the study aims to see if it can slow down memory decline.
This study tests a new drug called NSC001 for people with mild to moderate Alzheimer's. It checks if the drug is safe and if it might help slow memory decline. You'll need a caregiver who can join you at visits and help track your progress.
Hear when a new Alzheimer's Disease(AD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.